National Institute of Arthritis and Musculoskeletal and Skin Diseases; Notice of Meeting, 13604-13605 [2025-04968]
Download as PDF
<![CDATA[
13604
Federal Register / Vol. 90, No. 56 / Tuesday, March 25, 2025 / Notices
Date: June 4–6, 2025.
Time: 10:00 a.m. to 3:30 p.m.
Agenda: To review and evaluate grant
applications.
Address: National Institutes of Health,
National Institute of Diabetes and Digestive
and Kidney Diseases, Democracy II, Suite
7000A, 6707 Democracy Boulevard,
Bethesda, MD 20892.
Meeting Format: Virtual Meeting.
Contact Person: Charlene J. Repique, Ph.D.,
Scientific Review Officer, National Institute
of Diabetes and Digestive and Kidney
Diseases, National Institutes of Health, 6707
Democracy Boulevard, Bethesda, MD 20892–
5452, (301) 594–7791, charlene.repique@
nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.847, Diabetes,
Endocrinology and Metabolic Research;
93.848, Digestive Diseases and Nutrition
Research; 93.849, Kidney Diseases, Urology
and Hematology Research, National Institutes
of Health, HHS)
of Health, National Institute of Diabetes and
Digestive and Kidney Diseases, 6707
Democracy Boulevard, Rm. 7351, Bethesda,
MD 20892–2542, 301–594–8886, sanoviche@
mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.847, Diabetes,
Endocrinology and Metabolic Research;
93.848, Digestive Diseases and Nutrition
Research; 93.849, Kidney Diseases, Urology
and Hematology Research, National Institutes
of Health, HHS)
Dated: March 20, 2025.
David W. Freeman,
Supervisory Program Analyst, Office of
Federal Advisory Committee Policy.
National Institutes of Health
[FR Doc. 2025–05024 Filed 3–24–25; 8:45 am]
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of a
meeting of the National Advisory
Environmental Health Sciences Council.
The meeting will be open to the
public as indicated below, with
attendance limited to space available.
Individuals who plan to attend and
need special assistance, such as sign
language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Diabetes and
Digestive and Kidney Diseases; Notice
of Closed Meeting
ddrumheller on DSK120RN23PROD with NOTICES1
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Diabetes and Digestive and Kidney Diseases
Special Emphasis Panel; NIDDK RC2 Review.
Date: May 1, 2025.
Time: 11:00 a.m. to 1:00 p.m.
Agenda: To review and evaluate grant
applications.
Address: National Institutes of Health,
National Institute of Diabetes and Digestive
and Kidney Diseases, Democracy II, Suite
7000A, 6707 Democracy Boulevard,
Bethesda, MD 20892.
Meeting Format: Virtual Meeting.
Contact Person: Elena Sanovich, Ph.D.,
Scientific Review Officer, National Institutes
18:03 Mar 24, 2025
Jkt 265001
[FR Doc. 2025–04980 Filed 3–24–25; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institute of Environmental
Health Sciences; Notice of Meeting
BILLING CODE 4140–01–P
VerDate Sep<11>2014
Dated: March 19, 2025.
David W. Freeman,
Supervisory Program Analyst, Office of
Federal Advisory Committee Policy.
Name of Committee: National Advisory
Environmental Health Sciences Council; June
5, 2025 NAEHSC Meeting.
Date: June 5, 2025.
Open: 9:00 a.m. to 1:45 p.m.
Agenda: Call to Order, Review of
Confidentiality and Conflict of Interest,
Consideration of previous Meeting Minutes,
Report of the Directors, Collaboration with
NHLBI—CURE, and Impact of Environmental
Exposures on Gut-Brain Signaling in
Neurological Conditions (NIEHS Scientific
Concept).
Address: NIEHS/National Institutes of
Health, Building 4401, East Campus, 79 T.W.
Alexander Drive, Research Triangle Park, NC
27709, Virtual Meeting.
PO 00000
Frm 00025
Fmt 4703
Sfmt 4703
Closed: 2:00 p.m. to 4:00 p.m.
Agenda: To review and evaluate
consideration of Grant Applications and
Intramural BSC Report.
Meeting Format: Virtual.
Address: NIEHS/National Institutes of
Health, Building 4401, East Campus, 79 T.W.
Alexander Drive, Research Triangle Park, NC
27709.
Contact Person: David M. Balshaw, BA,
Ph.D., Director Division of Extramural
Research and Training, National Institute of
Environmental Health Sciences, P.O. Box
12233, MD EC–27, Research Triangle Park,
NC 27709–2233, 984–287–3234, email:
balshaw@niehs.nih.gov.
Any interested person may file written
comments with the committee by forwarding
the statement to the Contact Person listed on
this notice. The statement should include the
name, address, telephone number and when
applicable, the business or professional
affiliation of the interested person. In the
interest of security, NIH has procedures at
https://www.nih.gov/about-nih/visitorinformation/campus-access-security for
entrance into on-campus and off-campus
facilities. All visitor vehicles, including
taxicabs, hotel, and airport shuttles will be
inspected before being allowed on campus.
Visitors attending a meeting on campus or at
an off-campus Federal facility will be asked
to show one form of identification (for
example, a government-issued photo ID,
driver’s license, or passport) and to state the
purpose of their visit. Information is also
available on the Institute’s/Center’s home
page: www.niehs.nih.gov/dert/c-agenda.htm,
where an agenda and any additional
information for the meeting will be posted
when available.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.115, Biometry and Risk
Estimation—Health Risks from
Environmental Exposures; 93.142, NIEHS
Hazardous Waste Worker Health and Safety
Training; 93.143, NIEHS Superfund
Hazardous Substances—Basic Research and
Education; 93.894, Resources and Manpower
Development in the Environmental Health
Sciences; 93.113, Biological Response to
Environmental Health Hazards; 93.114,
Applied Toxicological Research and Testing,
National Institutes of Health, HHS)
Dated: March 20, 2025.
Bruce A. George,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2025–05018 Filed 3–24–25; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Arthritis and
Musculoskeletal and Skin Diseases;
Notice of Meeting
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of a
E:\FR\FM\25MRN1.SGM
25MRN1
Federal Register / Vol. 90, No. 56 / Tuesday, March 25, 2025 / Notices
ddrumheller on DSK120RN23PROD with NOTICES1
meeting of the National Arthritis and
Musculoskeletal and Skin Diseases
Advisory Council.
The meeting will be open to the
public as indicated below, with
attendance limited to space available.
Individuals who plan to attend and
need special assistance, such as sign
language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting. The open
session will be videocast and can be
accessed from the NIH Videocasting and
Podcasting website (https://
videocast.nih.gov/).
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Arthritis and
Musculoskeletal and Skin Diseases Advisory
Council.
Date: April 21, 2025.
Closed: 9:30 a.m. to 10:30 a.m.
Agenda: To review and evaluate grant
applications.
Address: National Institutes of Health, 31
Center Drive, Bethesda, MD 20892.
Open: 10:30 a.m. to 12:30 p.m.
Agenda: Call to Order; NIAMS Director’s
Report and Discussion; Open Discussion.
Address: National Institutes of Health, 31
Center Drive, Bethesda, MD 20892.
Meeting Format: Virtual Meeting.
Contact Person: Darren D. Sledjeski, Ph.D.,
Director, Division of Extramural Activities
(DEA), National Institute of Arthritis and
Musculoskeletal and Skin Diseases, 6701
Democracy Blvd., Bethesda, MD 20892, (301)
451–7766, darren.sledjeski@nih.gov.
Any interested person may file written
comments with the committee by forwarding
the statement to the Contact Person listed on
this notice. The statement should include the
name, address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
Information is also available on the
Institute’s/Center’s home page: https://
www.niams.nih.gov/about/working-groups/
advisory-council, where an agenda and any
additional information for the meeting will
be posted when available.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.846, Arthritis,
Musculoskeletal and Skin Diseases Research,
National Institutes of Health, HHS)
VerDate Sep<11>2014
18:03 Mar 24, 2025
Jkt 265001
13605
Dated: March 19, 2025.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory
Committee Policy.
Dated: March 19, 2025.
Bruce A. George,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2025–04968 Filed 3–24–25; 8:45 am]
[FR Doc. 2025–04969 Filed 3–24–25; 8:45 am]
BILLING CODE 4140–01–P
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institutes of Health
National Institute of Dental &
Craniofacial Research; Notice of
Meeting
Eunice Kennedy Shriver National
Institute of Child Health & Human
Development; Notice of Closed
Meeting
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of a
meeting of the National Advisory Dental
and Craniofacial Research Council.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Advisory
Dental and Craniofacial Research Council.
Date: April 18, 2025.
Closed: 11:00 a.m. to 12:00 p.m.
Agenda: To review and evaluate BSC
report to council.
Address: National Institute of Dental &
Craniofacial Research, 31 Center Drive,
Bethesda, MD 20892.
Meeting Format: Virtual Meeting.
Closed: 12:00 p.m. to 3:00 p.m.
Agenda: To review and evaluate grant
applications.
Address: National Institute of Dental &
Craniofacial Research, 31 Center Drive,
Bethesda, MD 20892.
Meeting Format: Virtual Meeting.
Contact Person: Yasaman Shirazi, Ph.D.,
Branch Chief, National Institute of Dental &
Craniofacial Research, National Institutes of
Health, 31 Center Drive, Bethesda, MD
20892, 301–594–5593, email:
yasaman.shirazi@nih.gov.
Information is also available on the
Institute’s/Center’s home page: https://
www.nidcr.nih.gov/about-us/advisorycommittees/advisory-council, where an
agenda and any additional information for
the meeting will be posted when available.
(Catalogue of Federal Domestic Assistance
Program No. 93.121, Oral Diseases and
Disorders Research, National Institutes of
Health, HHS)
PO 00000
Frm 00026
Fmt 4703
Sfmt 9990
Name of Committee: Eunice Kennedy
Shriver National Institute of Child Health
and Human Development Special Emphasis
Panel; Member Conflict: Maternal and
Pediatric Health.
Date: May 2, 2025.
Time: 9:00 a.m. to 12:30 p.m.
Agenda: To review and evaluate grant
applications.
Address: Eunice Kennedy Shriver National
Institute of Child Health and Human
Development, 6710 B Rockledge Drive,
Bethesda, MD 20892.
Meeting Format: Virtual Meeting.
Contact Person: Mei Qin, M.D., Ph.D.,
Scientific Review Branch, Eunice Kennedy
Shriver National Institute of Child Health
and Human Development, National Institutes
of Health, 6710B Rockledge Drive, Suite 401,
Bethesda, MD 20892, email: mei.qin@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.864, Population Research;
93.865, Research for Mothers and Children;
93.929, Center for Medical Rehabilitation
Research; 93.209, Contraception and
Infertility Loan Repayment Program, National
Institutes of Health, HHS)
Dated: March 20, 2025.
Bruce A. George,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2025–05017 Filed 3–24–25; 8:45 am]
BILLING CODE 4140–01–P
E:\FR\FM\25MRN1.SGM
25MRN1
]]>Agencies
[Federal Register Volume 90, Number 56 (Tuesday, March 25, 2025)]
[Notices]
[Pages 13604-13605]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2025-04968]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Arthritis and Musculoskeletal and Skin
Diseases; Notice of Meeting
Pursuant to section 1009 of the Federal Advisory Committee Act, as
amended, notice is hereby given of a
[[Page 13605]]
meeting of the National Arthritis and Musculoskeletal and Skin Diseases
Advisory Council.
The meeting will be open to the public as indicated below, with
attendance limited to space available. Individuals who plan to attend
and need special assistance, such as sign language interpretation or
other reasonable accommodations, should notify the Contact Person
listed below in advance of the meeting. The open session will be
videocast and can be accessed from the NIH Videocasting and Podcasting
website (https://videocast.nih.gov/).
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Arthritis and Musculoskeletal and
Skin Diseases Advisory Council.
Date: April 21, 2025.
Closed: 9:30 a.m. to 10:30 a.m.
Agenda: To review and evaluate grant applications.
Address: National Institutes of Health, 31 Center Drive,
Bethesda, MD 20892.
Open: 10:30 a.m. to 12:30 p.m.
Agenda: Call to Order; NIAMS Director's Report and Discussion;
Open Discussion.
Address: National Institutes of Health, 31 Center Drive,
Bethesda, MD 20892.
Meeting Format: Virtual Meeting.
Contact Person: Darren D. Sledjeski, Ph.D., Director, Division
of Extramural Activities (DEA), National Institute of Arthritis and
Musculoskeletal and Skin Diseases, 6701 Democracy Blvd., Bethesda,
MD 20892, (301) 451-7766, [email protected].
Any interested person may file written comments with the
committee by forwarding the statement to the Contact Person listed
on this notice. The statement should include the name, address,
telephone number and when applicable, the business or professional
affiliation of the interested person.
Information is also available on the Institute's/Center's home
page: https://www.niams.nih.gov/about/working-groups/advisory-council, where an agenda and any additional information for the
meeting will be posted when available.
(Catalogue of Federal Domestic Assistance Program Nos. 93.846,
Arthritis, Musculoskeletal and Skin Diseases Research, National
Institutes of Health, HHS)
Dated: March 19, 2025.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2025-04968 Filed 3-24-25; 8:45 am]
BILLING CODE 4140-01-P
